Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines

Cancer Research

Volumn 62, Issue 20, 2002, Pages 5897-5901

  Harada, Kenichi ^a   Toyooka, Shinichi ^a   Shivapurkar, Narayan ^b   Maitra, Anirban ^b   Reddy, Jyotsna L ^a   Matta, Hittu ^a   Miyajima, Kuniharu ^a   Timmons, Charles F ^c   Tomlinson, Gail E ^a,b   Mastrangelo, Domenico ^d   Hay, Robert J ^e   Chaudhary, Preet M ^a,b   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

^d UNIVERSITY OF SIENA   (Italy)

^e AMERICAN TYPE CULTURE COLLECTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 10; CASPASE 8;

ACUTE LEUKEMIA; APOPTOSIS; ARTICLE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; CPG ISLAND; EWING SARCOMA; GANGLIONEUROMA; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; HEPATOBLASTOMA; HUMAN; HUMAN CELL; LUNG TUMOR; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; METHYLATION; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROENDOCRINE TUMOR; OSTEOSARCOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETINOBLASTOMA; RHABDOMYOSARCOMA; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

AZACITIDINE; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 10; CASPASE 8; CASPASE 9; CASPASES; CHILD; DNA METHYLATION; ENZYME INHIBITORS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GENES, TUMOR SUPPRESSOR; HUMANS; HYDROXAMIC ACIDS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0037108859     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Weber, C. H., and Vincenz, C. A docking model of key components of the DISC complex: Death domain superfamily interactions redefined. FEBS Lett., 492: 171-176, 2001
2. Fulda, S., Sieverts, H., Friesen, C., Herr, I., and Debatin, K. M. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res., 57: 3823-3829, 1997
3. Rehemtulla, A., Hamilton, C. A., Chinnaiyan, A. M., and Dixit, V. M. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J. Biol. Chem., 272: 25783-25786, 1997
4. Grenet, J., Teitz, T., Wei, T., Valentine, V., and Kidd, V. J. Structure and chromosome localization of the human CASP8 gene. Gene (Amst.), 226: 225-232, 1999
5. Kischkel, F. C., Lawrence, D. A., Tinel, A., LeBlanc, H., Virmani, A., Schow, P., Gazdar, A., Blenis, J., Arnott, D., and Ashkenazi, A. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J. Biol. Chem., 276: 46639-46646, 2001
6. Han, D. K., Chaudhary, P. M., Wright, M. E., Friedman, C., Trask, B. J., Riedel, R. T., Baskin, D. G., Schwartz, S. M., and Hood, L. MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. Proc. Natl. Acad. Sci. USA, 94: 11333-11338, 1997
7. Teitz, T., Wei, T., Valentine, M. B., Vanin, E. F., Grenet, J., Valentine, V. A., Behm, F. G., Look, A. T., Lahti, J. M., and Kidd, V. J. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med., 6: 529-535, 2000
8. Teitz, T., Lahti, J. M., and Kidd, V. J. Aggressive childhood neuroblastomas do not express caspase-8: An important component of programmed cell death. J. Mol. Med., 79: 428-436, 2001
9. Takita, J., Yang, H. W., Bessho, F., Hanada, R., Yamamoto, K., Kidd, V., Teitz, T., Wei, T., and Hayashi, Y. Absent or reduced expression of the caspase 8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma. Med. Pediatr. Oncol., 35: 541-543, 2000
10. Hopkins-Donaldson, S., Bodmer, J. L., Bourloud, K. B., Brognara, C. B., Tschopp, J., and Gross, N. Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis. Med. Pediatr. Oncol., 35: 608-611, 2000
11. Zuzak, T. J., Steinhoff, D. F., Sutton, L. N., Phillips, P. C., Eggert, A., and Grotzer, M. A. Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma. Eur. J. Cancer, 38: 83-91, 2002
12. Fulda, S., Kufer, M. U., Meyer, E., van Valen, F., Dockhorn-Dworniczak, B., and Debatin, K. M. Sensitization for death receptor- or drug-induced apoptosis by reexpression of caspase-8 through demethylation or gene transfer. Oncogene, 20: 5865-5877, 2001
13. Shivapurkar, N., Toyooka, S., Eby, M. T., Huang, C. X., Sathyanarayana, U. G., Cunningham, H. T., Reddy, J. L., Brambilla, E., Takahashi, T., Minna, J. D., Chaudhary, P. M., and Gazdar, A. F. Differential inactivation of caspase-8 in lung cancer. Cancer Biol. Ther., 1: 65-69, 2002
14. Herrmann, B. G., and Frischauf, A. M. Isolation of genomic DNA. Methods Enzymol., 152: 180-183, 1987
15. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA. 93: 9821-9826, 1996
16. Mollerup, S., Ryberg, D., Hewer, A., Phillips, D. H., and Haugen, A. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res., 59: 3317-3320, 1999
17. Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., Sekido, Y., Latif, F., Milchgrub, S., Toyooka, S., Gazdar, A. F., Lerman, M. I., Zabarovsky, E., White, M., and Minna, J. D. Epigenetic inactivation of RASSFIA in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. (Bethesda), 93: 691-699, 2001
18. Harada, K., Toyooka, S., Maitra, A., Maruyama, R., Toyooka, K. O., Timmons, C. F., Tomlinson, G. E., Mastrangelo, D., Hay, R. J., Minnal, J. D., and Gazdar, A. F. Aberrant promoter methylation and silencing of the RASSFIA gene in pediatric tumors and cell lines. Oncogene, 21: 4345-4349, 2002
19. Scaffidi, C., Medema, J. P., Krammer, P. H., and Peter, M. E. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J. Biol. Chem., 272: 26953-26958, 1997
20. Gardiner-Garden, M., and Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol., 196: 261-282, 1987
21. Takita, J., Yang, H. W., Chen, Y. Y., Hanada, R., Yamamoto, K., Teitz, T., Kidd, V., and Hayashi, Y. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene, 20: 4424-4432, 2001
22. Astuti, D., Agathanggelou, A., Honorio, S., Dallol, A., Martinsson, T., Kogner, P., Cummins, C., Neumann, H. P., Voutilainen, R., Dahia, P., Eng, C., Maher, E. R., and Latif, F. RASSFIA promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumors. Oncogene. 20: 7573-7577, 2001
23. Eggert, A., Grotzer, M. A., Zuzak, T. J., Wiewrodt, B. R., Ikegaki, N., and Brodeur, G. M. Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Med. Pediatr. Oncol., 35: 603-607, 2000
24. Grotzer, M. A., Eggert, A., Zuzak, T. J., Janss, A. J., Marwaha, S., Wiewrodt, B. R., Ikegaki, N., Brodeur, G. M., and Phillips, P. C. Resistance to TRAIL-induced apoptosis in primitive neuraectodermal brain tumor cells correlates with a loss of caspase-8 expression. Oncogene. 19: 4604-4610, 2000
25. Hanahan, D., and Weinberg, R. A. The hallmarks of cancer. Cell. 100: 57-70, 2000